Results 191 to 200 of about 107,483 (325)
Does ethnicity matter in male hormonal contraceptive efficacy? [PDF]
Niloufar Ilani +3 more
openalex +1 more source
Male Contraceptive Uptake and Associated Socio-Economic Characteristics in Kenya
Anderson M. Mwito +2 more
openalex +2 more sources
Toward gender equity in contraception: male contraceptive passes safety trial. [PDF]
eBioMedicine.
europepmc +1 more source
Carfilzomib is highly effective in the treatment of multiple myeloma, but it has been associated with cardiovascular adverse events that impact patient outcomes. Our prior global metabolomic analyses indicated an association between hydrophilic bile acids and carfilzomib‐cardiotoxicity risk, although a causal relationship remained to be determined ...
Samia Shabnaz +15 more
wiley +1 more source
“Cassia auriculata-derived silver nanoparticles as a novel male contraceptive agent”
Prity Yadav +3 more
openalex +1 more source
RISUG® as a male contraceptive: journey from bench to bedside. [PDF]
Khilwani B +3 more
europepmc +1 more source
ABSTRACT Objective Binge eating disorder (BED) is maintained by increased food‐related incentive salience, which is reflected by an attentional bias for food. Oxytocin acutely attenuates this bias in patients with anorexia nervosa and reduces food intake in males with normal or increased body weight.
Julia Nannt +6 more
wiley +1 more source
From Discovery to Clinical Trial: YCT-529, an Oral NonHormonal Male Contraceptive Targeting the Retinoic Acid Receptor Alpha. [PDF]
Shi R +12 more
europepmc +1 more source
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya +9 more
wiley +1 more source

